Introduction
============

Chondrosarcoma is the second most commonly occurring primary bone malignancy, which affects the pelvis, long bones and the spine, in addition to the larynx, head and neck, and it eventually metastasizes ([@b1-mmr-17-05-7184]--[@b3-mmr-17-05-7184]). Currently, chondrosarcoma remains largely incurable due to poor prognosis and a high rate of recurrence ([@b4-mmr-17-05-7184]). Thus, the development of innovative therapies for this disease is required.

Pyrroloquinoline quinone (PQQ) is a nutrient widely distributed in nature and serves as a noncovalently bound redox cofactor in a series of bacterial quinoprotein dehydrogenases ([@b5-mmr-17-05-7184]). PQQ scavenges reactive oxygen species (ROS) in bacteria ([@b6-mmr-17-05-7184]). Previous studies have demonstrated that PQQ protected isolated liver mitochondria from damage following oxidative stress ([@b7-mmr-17-05-7184]) and scavenged superoxide radicals ([@b8-mmr-17-05-7184],[@b9-mmr-17-05-7184]). A previous study revealed that PQQ could induce apoptosis in human promonocytic leukemia U937 and lymphoma EL-4 cells, in addition to Jurkat cell programmed death ([@b7-mmr-17-05-7184]). The underlying mechanism may be relevant to the increase in intracellular ROS and the depletion of glutathione (GSH) ([@b10-mmr-17-05-7184]). In addition, PQQ may induce tumor cell (A549, Neuro-2A and HCC-LM3) apoptosis by decreasing the expression of B-cell lymphoma 2 ([@b11-mmr-17-05-7184]).

Oxidative stress arises from an imbalanced redox status between the production of ROS and the biological system able to remove them. ROS, including superoxide (O~2~^−^), hydroxyl radical (•OH) and H~2~O~2~, are constantly generated in aerobic organisms ([@b12-mmr-17-05-7184]). ROS can cause fatal lesions in cells under oxidative stress, leading to a number of diseases including cancer ([@b13-mmr-17-05-7184]). High levels of ROS are detrimental and induce cell apoptosis or necrosis ([@b14-mmr-17-05-7184],[@b15-mmr-17-05-7184]). Recently, 'oxidation therapy' has been developed by inducing cytotoxic oxidative stress for cancer treatment. A number of antitumor agents, including vinblastine, cisplatin, doxorubicin, camptothecin and several others have exhibited antitumor activity via the ROS-dependent activation of apoptotic cell death, suggesting the potential use of ROS as an antitumor agent ([@b16-mmr-17-05-7184]). However, the mechanisms underlying the role of PQQ in regulating chondrosarcoma cells have not been fully elucidated.

The present study examined the role of PQQ in chondrosarcoma cells, and identified that PQQ could increase cell apoptosis and the level of ROS. PQQ reduced the ability of scavenging oxygen free radicals by inhibiting the activation of superoxide dismutase (SOD)1 and SOD2, and the formation of GSH, causing an increased level of ROS. Additionally, an animal model was established *in vivo*, which identified that PQQ inhibited the proliferation of transplanted tumor cells, increased cell apoptosis through ROS and increased DNA damage. Thus, PQQ may be a desirable drug for cancer treatment in the future.

Materials and methods
=====================

### Cell culture and reagents

The chondrosarcoma SW1353 cells, osteosarcoma Saos-2 cells and 293 cells were purchased from American Type Culture Collection (Manassas, VA, USA). Human XJH B lymphocytes were purchased from the Institute of Biochemistry and Cell Biology, the Chinese Academy of Sciences (Shanghai, China). All cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) and 1% penicillin/streptomycin (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). All cells were maintained at 37°C with 5% CO~2~ in an incubator with a constant humidity. PQQ was purchased from Sigma-Aldrich (Merck KGaA).

### Cell cytotoxicity death analysis

Cell cytotoxic death was assessed using a CytoTox-Glo^™^ Cytotoxicity assay (Promega Corporation, Madison, WA, USA) according to the manufacturer\'s protocols. Briefly, all of the cells were seeded in at a density of 1×10^4^ cells per well in 3 ml culture medium and incubated at 37°C in 5% CO~2~ for 6 h. All of cells were incubated in culture medium with indicated concentration of PQQ (0, 40, 80, 120 and 200 µM) for 24 h or 120 µM PQQ on SW1353 cells at different time points (6, 12, 24, 36 and 48 h). A total of 50 µl CytoTox-Glo^™^ Reagent was first added and incubated at room temperature for 15 min, luminescence was measured to determine dead cell luminescence. Then lysis reagent was added and luminescence was measured to determine total cell luminescence after 15 min of incubation at room temperature. The luminescent signal was adjusted to reflect the 'live cell' contribution by subtracting the initial dead cell signal.

### Western blot analysis

The SW1353 cells were lysed with cell lysis buffer 10X (cat. no. 9803; Cell Signaling Technology, Inc., Danvers, MA, USA), which contained protease inhibitors (Sigma-Aldrich; Merck KGaA). Then cells were centrifuged at 12,000 × g for 5 min at 4°C. The supernatant was collected and a bicinchoninic acid Protein Assay kit (Sigma-Aldrich; Merck KGaA) was used to measure the protein concentration. The protein samples (20 µg/lane) were separated by 10% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (EMD Millipore, Billerica, MA, USA). Membranes were blocked with Tris-buffered saline (TBS) and 0.1% Tween-20 (TBS/T) containing 5% bovine serum albumin (Sangon Biotech Co., Ltd., Shanghai, China) at 37°C for 2 h, and incubated overnight at 4°C with primary antibodies (Abcam, Cambridge, MA, USA; SOD1 and SOD2; 1:1,000 in TBS/T; SOD1; cat. no. ab13498; SOD2, cat. no. ab13534). The membrane was washed 3 times with TBS/T and then incubated with a horseradish peroxidase (HRP)-labeled secondary antibody (Cell Signaling Technology, Inc.; 1:2,000 in TBS/T; cat no. 7074) for 2 h at room temperature. The protein bands were detected by chemiluminescence (GE Healthcare, Piscataway, NJ, USA). Bands were quantified by densitometry using Image Lab 5.0 software (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and β-actin (Cell Signaling Technology, Inc.; 1:2,000; cat no. 4970) was used as an internal control.

### Cell apoptosis analysis

SW1353 and Saos-2 cells were seeded into 6-well plates at a density of 2×10^5^ cells/well with the complete medium and grown for 24 h. Following incubation, cells were exposed to 120 µM PQQ or 200 µl PBS (control group) at 37°C in a 5% CO~2~ humidified atmosphere. Following treatment for 48 h, cells were processed with trypsin EDTA (0.25%) solution and centrifuged at 1,000 × g for 5 min at 4°C. Following washing twice with PBS, 10 µl Annexin V-fluorescein isothiocyanate and 5 µl propidium iodide (BD Biosciences, Franklin Lakes, NJ, USA) were added and incubated for 15 min in the dark at room temperature. Subsequently, apoptotic cells were detected by flow cytometry using a FACSC alibur system with Cell Quest software version 5.1 (BD Biosciences).

### Intracellular ROS measurement

2′,7′-Dichlorodihydrofluorescein diacetate (DCFH-DA) was used as a probe for cellular ROS in the present study. SW1353 cells (2×10^5^/well) in a 6-well plate were incubated with PQQ (120 µM) for 24 h. Following incubation in serum-free medium containing 20 µM DCFH-DA for 20 min at 37°C, cells in each well were washed three times with PBS, digested by pancreatic enzymes at 37°C for 3 min and immediately subjected to ROS measurement by flow cytometry analysis using Cytomics FC 500 MCL (Beckman Coulter, Inc., Brea, CA, USA). The wavelength was 488 nm for excitation and 525 nm for emission.

### Hydroxyl radical (•OH) measurement

The deoxyribose degradation method was used to detect the level of •OH as described by Baliga ([@b17-mmr-17-05-7184]). Briefly, 2-deoxy-d-ribose at 3 mM was added to cells just prior to the addition of PQQ. After incubation, 0.5 ml of medium was collected and mixed with 0.5 ml of 1% (w/v) 2-thiobarbituric acid in 50 mM NaOH and 0.5 ml of 2.8% (w/v) trichloroacetic acid. The mixture was then heated at 100°C for 15 min, cooled, and extracted with n-butanol. The supernatant was measured for absorbance at 532 nm.

### GSH production

A GSH Assay kit (Beyotime Institute of Biotechnology, Shanghai, China) was used to assess the content of GSH according to the manufacturer\'s protocols ([@b18-mmr-17-05-7184]).

### Tumor xenograft experiments

Experimental procedures were conducted in conformity with institutional guidelines (The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China) for the care and use of laboratory animals, and ethical approval was obtained from The Second Affiliated Hospital of Zhejiang University School of Medicine. Procedures also conformed to the National Institutes of Health Guide for Care and Use of Laboratory Animals ([@b19-mmr-17-05-7184]). A mouse model of chondrosarcoma was established using SW1353 cells to generate subcutaneous xenografts. A total of 12 Male BALB/c nude mice (6 week-old, 18--22 g) were obtained from the Shanghai Laboratory Animal Center, Chinese Academy Sciences (Shanghai, China), and housed in a controlled 12-h light/dark cycle environment at 20--25°C with free access to food and water. The mice were randomly divided into 2 groups (n=6/group). Briefly, \~1×10^6^ cells/mouse were injected subcutaneously once into the lateral flanks of BALB/c nude mice and 1 tumor per mouse was grown over 10--14 days until they almost reached 100--150 mm^3^. The mice were then intraperitoneally injected with 50 mg/kg PQQ or 200 µl PBS once daily for 10 days. Following 10 days, the mice were sacrificed and the tumor xenografts were harvested. The tumor volume was measured and calculated as follows: Volume=(width^2^ × length)/2. The tumor tissues were stored in −80°C.

### Immunohistochemistry

Sections (4-µm) of tumor tissues which were cut using a LEICA RM2235 (Leica Microsystems GmbH, Wetzlar, Germany) and then were fixed in a 10% formalin solution (Sigma-Aldrich; Merck KGaA) for 24 h at room temperature, embedded in paraffin wax (Sigma-Aldrich; Merck KGaA). Then they were deparaffinized with xylene for 10 min twice, 100% ethyl alcohol (Sangon Biotech Co., Ltd., Shanghai, China) for 5 min twice, 95% ethyl alcohol for 5 min, 85% ethyl alcohol for 5 min, 75% ethyl alcohol for 5 min, PBS washed three times. Next, the endogenous peroxidase activity was quenched using 3% H~2~O~2~ and nonspecific binding was blocked with 5% FBS at room temperature for 20 min. Following incubation with primary antibody proliferating cell nuclear antigen (PCNA) and index γ-H2A histone member X (γ-H2AX; Abcam, Cambridge, MA, USA; PCNA cat. no. ab18197, γ-H2AX; cat. no. ab2893; all diluted 1:1,000 in TBS/T) overnight at 4°C, the sections were further incubated with the corresponding HRP-conjugated secondary antibody (Cell Signaling Technology, Inc.; 1:2,000 in TBS/T; cat. no. 7074) for 1 h at room temperature. The target protein expression was visualized using 3,3′-diaminobenzidine and hematoxylin counterstaining was also performed at room temperature for 3 min. The negative control was established using PBS rather than the primary antibody. The sections were observed under light microscopy (Olympus Corporation, Tokyo, Japan). The positive rates were measured using Image-Pro Plus v 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA).

### In situ quantification of apoptotic cells

Apoptotic cells were detected using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and an *in situ* cell death detection kit (Roche Diagnostics, Basel, Switzerland) according to the manufacturer\'s protocols. Stained sections were visualized under a fluorescence microscope. TUNEL-positive cells with brown staining and all cells with nuclear hematoxylin counterstaining for 30 sec at room temperature were counted within 5 randomly selected fields under high-power magnification (DM-2,500; Leica Microsystems GmbH). The index of apoptosis was expressed as the ratio of positively stained apoptotic cells to the total number of cells counted, ×100%.

### Statistical analysis

Data were expressed as the mean ± standard deviation (n=3) and analysis was performed using Prism 5 software (Graph Pad Software, Inc., La Jolla, CA, USA). UCSF DOCK 6.5 Software (University of California, San Francisco, CA, USA) was used to analyze the molecular docking. Statistical differences between two groups were examined with the Student\'s t-test and multiple groups were compared using one-way analysis of variance followed by Tukey\'s post hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### PQQ enhances the apoptotic rate in chondrosarcoma SW1353 cells

To determine whether PQQ has a role in causing chondrosarcoma cell death, a cell cytotoxicity assay was performed to measure cell viability. SW1353, Saos-2, 293 and XJH B cells were treated with different concentrations of PQQ (0, 40, 80, 120 and 200 µM) for 24 h. The results demonstrated that chondrosarcoma SW1353 cells and osteosarcoma Saos-2 cells had a greater percentage of apoptosis than normal human 293 and XJH B cells, which increased in a PQQ concentration-dependent manner ([Fig. 1A](#f1-mmr-17-05-7184){ref-type="fig"}). It was identified that 120 µM PQQ treatment significantly increased the cell death rate in a time-dependent manner as measured by a cell cytotoxicity analysis ([Fig. 1B](#f1-mmr-17-05-7184){ref-type="fig"}). Flow cytometry was used to measure the apoptotic rates of chondrosarcoma SW1353 cells. It was identified that treatment with PQQ markedly increased the number of apoptotic SW1353 and Saos-2 cells when compared with the PBS treatment groups ([Fig. 1C and D](#f1-mmr-17-05-7184){ref-type="fig"}). These results indicated that cell death was increased in a dose- and time-dependent manner, while the effect on normal cells was relatively small.

### PQQ enhances the level of ROS

To determine whether PQQ-induced cell apoptosis was associated with oxidative stress levels in chondrosarcoma SW1353 cells, DCFH-DA staining and flow cytometry were used to detect the changes in the levels of ROS and hydroxyl radicals in SW1353 cells treated with 120 µM PQQ for 24 h. It was identified that the level of ROS and hydroxyl radicals increased when compared with the control PBS group (P\<0.05 and P\<0.01; [Fig. 2](#f2-mmr-17-05-7184){ref-type="fig"}). These results demonstrated that PQQ treatment increased oxidative stress levels in chondrosarcoma SW1353 cells.

### PQQ inhibits the activity of SOD1 and SOD2, and reduces GSH production

To investigate the molecular mechanism of PQQ-induced oxidative stress in chondrosarcoma SW1353 cells, western blotting was performed to detect the total SOD activity and to examine the expression of SOD1 and SOD2 protein. The results indicated that, when compared with control, the total SOD activity was reduced when cells were treated with different concentration of PQQ (0, 40, 80 and 120 µM) PQQ for 24 h ([Fig. 3A](#f3-mmr-17-05-7184){ref-type="fig"}); however, no significant difference was observed in SOD1 and SOD2 protein expression ([Fig. 3B](#f3-mmr-17-05-7184){ref-type="fig"}). Molecular docking software UCSF DOCK 6.5 (University of California) was used to test molecular docking simulations of PQQ with SOD1 and SOD2 protein, respectively. It was observed that PQQ formed 3 hydrogen bonds with the amino acids that surround the SOD1 activity center ([Fig. 3C](#f3-mmr-17-05-7184){ref-type="fig"}; [Table I](#tI-mmr-17-05-7184){ref-type="table"}). Similarly, PQQ formed 4 hydrogen bonds with the amino acids that surround the SOD1 activity center ([Fig. 3D](#f3-mmr-17-05-7184){ref-type="fig"}; [Table II](#tII-mmr-17-05-7184){ref-type="table"}). The content of GSH was also detected, and it was identified that GSH content was significantly decreased following treatment with different concentrations of PQQ (0, 40, 80 and 120 µM) for 24 h ([Fig. 3E](#f3-mmr-17-05-7184){ref-type="fig"}). These results indicated that PQQ can decrease the level of ROS by inhibiting the activities of SOD1 and SOD2, and the production of GSH, reducing the ability of scavenging oxygen free radicals in chondrosarcoma SW1353 cells.

### PQQ increases the inhibitory effect on tumorigenesis in vivo

To clarify the effect of PQQ *in vivo*, SW1353 cells were xenografted into BALB/c nude mice. When compared with the PBS control, the tumor volume of the PQQ treated group was significantly smaller ([Fig. 4A and B](#f4-mmr-17-05-7184){ref-type="fig"}). Immunohistochemistry analysis demonstrated that the percentage of PCNA positive cells was decreased and in TUNEL analysis the number of apoptotic cells increased when compared with the PBS control ([Fig. 4C and D](#f4-mmr-17-05-7184){ref-type="fig"}). These findings indicated that PQQ may inhibit the proliferation and promote the apoptosis of tumor cells.

### PQQ increases the level of ROS and DNA damage in tumor xenograft cells

To clarify whether PQQ decreased the proliferation of tumor xenograft cells and if increased apoptosis was associated with ROS, the ROS and DNA damage associated index γ-H2AX was detected in the tumors. The results demonstrated that the levels of ROS in the PQQ treated group were significantly higher compared with the PBS control group ([Fig. 5A and B](#f5-mmr-17-05-7184){ref-type="fig"}), and the percentage of γ-H2AX was significantly increased ([Fig. 5C and D](#f5-mmr-17-05-7184){ref-type="fig"}). These results suggested that PQQ increased intracellular ROS and caused DNA damage in transplanted cells.

Discussion
==========

Chondrosarcoma is a malignant tumor of mesenchymal origin that is generally locally aggressive and tends to produce early systemic metastases. However, chondrosarcoma does not respond to chemotherapy or radiation. Therefore, novel therapies are required. PQQ was first identified in bacteria and is also likely to be important in mammals ([@b20-mmr-17-05-7184]--[@b22-mmr-17-05-7184]). Previous studies on PQQ have been focused on its activities as an antioxidant and redox modulator ([@b7-mmr-17-05-7184]), a cardio- and neuro-protectant ([@b23-mmr-17-05-7184],[@b24-mmr-17-05-7184]), and its radio-protective effects on the hemopoietic system ([@b25-mmr-17-05-7184]). PQQ has a potent antitumor effect and possesses a significant cytotoxic effect on human lung adenocarcinoma, hepatocarcinoma, melanoma cells and brain cancer; however, it exhibits little effect on normal cells, which suggests that PQQ may be an effective therapeutic drug in the future ([@b7-mmr-17-05-7184],[@b11-mmr-17-05-7184],[@b26-mmr-17-05-7184]). However, the molecular mechanism of PQQ underlying its effect on chondrosarcoma remains to be elucidated.

The present study examined cell death following treatment with or without different concentrations of PQQ in cancer and normal cells. It was identified that cell death increased in a dose- and time-dependent manner following treatment with PQQ, while the effect on normal cells was relatively small. Cell death occurs in a variety of ways, including apoptosis, necrosis and cell autophagy ([@b27-mmr-17-05-7184],[@b28-mmr-17-05-7184]); however, the most frequently studied and most common type is apoptosis. In the present study it was hypothesized whether the effect of PQQ on chondrosarcoma cells was achieved by promoting the rate of apoptosis in chondrosarcoma cells. In the present study, the apoptotic level following PQQ treatment in SW1353 and Saos-2 cells was investigated by flow cytometry. The results demonstrated a large level of apoptosis occurred following PQQ treatment, and the proportion of cell apoptosis was comparable to that of the cytotoxic cell death rate, indicating that PQQ may mainly induce apoptosis to kill chondrosarcoma cells. Previous studies have reported that PQQ may cause apoptosis by inhibiting the synthesis of GSH and producing H~2~O~2~ via autoxidation to increase the level of oxidative stress in tumor cells ([@b7-mmr-17-05-7184],[@b11-mmr-17-05-7184]). It is well known that ROS induces cell death, including apoptosis. In addition, the enhancement of ROS production has long been associated with the apoptotic response induced by several anticancer agents ([@b29-mmr-17-05-7184]--[@b31-mmr-17-05-7184]). The status of intracellular redox is regulated by antioxidant enzymes (including SOD, catalase and GSH peroxidase) and non-enzymatic antioxidants (such as GSH and vitamin C) ([@b11-mmr-17-05-7184]). The levels of ROS and hydroxyl radicals in the PQQ treated and the PBS control groups were compared using flow cytometry and deoxyribose degradation method. The results suggested that PQQ can cause a significant increase in oxidative stress levels in the SW1353 chondrosarcoma cell line.

It was demonstrated that treatment with PQQ had inhibitory effects on tumorigenesis and decreased tumor size when compared with the control *in vivo*, which is similar to the results of the *in vitro* studies. However, it is unclear whether the mechanism of PQQ inhibition in the xenograft tumors is consistent with the *in vitro* results. These findings indicated that the levels of ROS in the PQQ treated group were significantly higher than those in the PBS control group, and the percentage of γ-H2AX positive cells in the DNA injury-associated indexes was significantly increased. The results suggested that PQQ may inhibit the proliferation of tumor xenograft cells by promoting oxidative stress and increasing the percentage of γ-H2AX. In conclusion, the mechanism underlying PQQ-induced apoptosis may be associated with increasing the levels of ROS, suggesting that PQQ may be a potential drug for chondrosarcoma therapies.
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![(A) Different PQQ sensitivity in SW1353, Saos-2, 293 and XJH B cells. All cells were incubated with PQQ (0, 40, 80, 120 or 200 µM) for 48 h. Cell viability was measured using cell cytotoxicity assay. \*P\<0.05, \*\*P\<0.01, \*\*\*P\<0.001 vs. PQQ (0 µM). (B) Effects of PQQ (120 µM) on SW1353 cells at different time points (6, 12, 24, 36 and 48 h). \*P\<0.05 and \*\*\*P\<0.001 vs. 6 h. (C) The number of apoptotic cells was determined by flow cytometry in SW1353 and Saos-2 cells following treatment with PQQ for 24 h. (D) The rate of apoptosis represented as a histogram. \*\*\*P\<0.001 vs. PBS treatment. PQQ, pyrroloquinoline quinone; PI, propidium iodide; AV, Annexin V-fluorescein isothiocyanate.](MMR-17-05-7184-g00){#f1-mmr-17-05-7184}

![(A) Flow cytometry was used to detect ROS levels following treatment with or without PQQ for 24 h. (B) Histogram of the levels of ROS in SW1353 cells treated with 120 µM PQQ for 24 h. (C) Deoxyribose degradation method was used to determine the levels of OH in SW1353 cells treated with 120 µM PQQ for 24 h. \*P\<0.05 and \*\*P\<0.01 vs. PBS treatment. ROS, reactive oxygen species; PQQ, pyrroloquinoline quinone;·OH, hydroxyl radicals.](MMR-17-05-7184-g01){#f2-mmr-17-05-7184}

![Western blot analysis was performed to analyze the protein levels of (A) total SOD, and (B) SOD1 and SOD2 in SW1353 cells. (C) A schematic diagram of PQQ combined with SOD1. (D) Schematic diagrams of PQQ combined with SOD2. (E) The level of GSH in chondrosarcoma SW1353 cells treated with or without PQQ. \*P\<0.05 and \*\*P\<0.01 vs. PBS. SOD, superoxide dismutase; T-SOD, total SOD; PQQ, pyrroloquinoline quinone; GSH, glutathione.](MMR-17-05-7184-g02){#f3-mmr-17-05-7184}

![(A) Compared with the PBS group, treatment with PQQ delayed tumor growth and decreased tumor size. (B) The tumor volume of those treated with PQQ was reduced when compared with the PBS group. (C) PCNA was used to detect the proliferation of tumor cells. Scale bar 50 µM. (D) Immunostaining with TUNEL was used to examine cell apoptosis. \*\*P\<0.01 vs. PBS. PQQ, pyrroloquinoline quinone; PCNA, proliferating cell nuclear antigen; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.](MMR-17-05-7184-g03){#f4-mmr-17-05-7184}

![(A) Flow cytometry was used to detect (B) ROS levels in tumor xenograft cells. (C) Immunohistochemical staining was used to detect γ-H2AX and (D) the histogram presents the percentage of γ-H2AX positive cells. \*P\<0.05 vs. PBS. PQQ, pyrroloquinoline quinone; ROS, reactive oxygen species; γ-H2AX, γ-H2A histone member X.](MMR-17-05-7184-g04){#f5-mmr-17-05-7184}

###### 

Pyrroloquinoline quinone combined with superoxide dismutase 1 hydrogen bond.

  X-H...Y                         *d*~(X-H)~(A)   *d*~(H...Y)~(A)   *d*~(X...Y)~(A)   ∠XHY(°)
  ------------------------------- --------------- ----------------- ----------------- ---------
  Molecule:O~13~...H~22~: LYS9    1.04            1.90              2.69              130
  Molecule:O~12~...H~N~: VAL148   1.00            2.06              2.79              128
  Molecule:H~27~...O: VAL148      0.95            1.97              2.76              139

###### 

Pyrroloquinoline quinone combined with superoxide dismutase 2 hydrogen bond.

  X-H...Y                           *d*~(X-H)~(A)   *d*~(H...Y)~(A)   *d*~(X...Y)~(A)   ∠XHY(°)
  --------------------------------- --------------- ----------------- ----------------- ---------
  Molecule:O~20~...HE~21~:GLN69     1.00            2.02              2.77              129
  Molecule:O~21~...HE~21~:GLN69     1.00            2.28              3.06              134
  Molecule:N~16~...HE~22~:GLN69:D   1.00            2.11              3.10              170
  Molecule:H~27~...O:GLN154         0.95            2.13              2.81              127
